Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$478,618,525
+$22,845,394 QoQ
Shares Held
1,901,997
-9.2% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
#86
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $3,615,172,375 across 15 Drug Manufacturers - General names. ABBV ranks #3 (13.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BMY |
Bristol Myers Squibb Co
|
11,593,352 | $668,008,942 | |
| 2 | LLY |
ELI LILLY & Co
|
508,522 | $609,936,593 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
1,901,997 | $478,618,525 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,695,329 | $474,849,776 | |
| 5 | AZN |
Astrazeneca PLC
|
2,262,369 | $428,990,409 | |
| 6 | GSK |
GSK plc
|
6,660,434 | $349,139,950 | |
| 7 | JNJ |
Johnson & Johnson
|
1,361,700 | $345,830,949 | |
| 8 | NVO |
Novo Nordisk A S
|
2,736,697 | $131,197,254 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $478,618,525 | 1,901,997 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $455,773,131 | 2,095,605 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $313,017,590 | 1,369,940 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $276,870,438 | 1,195,778 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $95,387,704 | 513,887 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $29,910,237 | 142,756 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $24,010,113 | 135,116 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $23,231,349 | 117,639 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $42,835,576 | 249,741 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $55,941,848 | 307,204 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $54,645,056 | 352,617 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $52,907,803 | 354,943 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $41,101,137 | 305,063 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $65,870,489 | 413,318 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $46,536,407 | 287,955 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $39,934,722 | 297,554 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $73,065,284 | 477,052 | Shares | Defined | 2022-08-09 | |
| 2022-03-31 | $69,298,782 | 427,480 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $368,017 | 2,718 | Shares | Defined | 2022-02-10 | |
| 2021-09-30 | $293,190 | 2,718 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $1,626,408 | 14,439 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $1,562,588 | 14,439 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $1,547,138 | 14,439 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,264,712 | 14,439 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $1,417,621 | 14,439 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $1,100,107 | 14,439 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||